Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2004; 44:20-24, doi:10.1016/j.jacc.2004.02.056
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Heijden, D. J.
Right arrow Articles by Laarman, G.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Heijden, D. J.
Right arrow Articles by Laarman, G.-J.

Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation

Dirk J. van der Heijden, MD*, Iris C. D. Westendorp, MD, MSc, PhD*, Robert K. Riezebos, MD*, Ferdinand Kiemeneij, MD, PhD*, Ton Slagboom, MD*, L. Ron van der Wieken, MD* and Gert-Jan Laarman, MD, PhD*,*

* Amsterdam Department for Intervention Cardiology (ADIC), Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands



View larger version (20K):

[in a new window]
 
Figure 1 Scatter plot showing the distribution of highest troponin values of patients in the two treatment regimes.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement